Evidence map›Paper›PMID 31270445›Full record

ArticleNature nanotechnology2019

Challenges in the implementation of MIRIBEL criteria on nanobiomed manuscripts.

Helena F Florindo, Asaf Madi, Ronit Satchi-Fainaro

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature nanotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Nanomaterial-based contrast agents.Nature reviews. Methods primers · 2023
    Article
  4. Article
  5. Nanodelivery of nucleic acids.Nature reviews. Methods primers · 2022
    Article
  6. Article
  7. The solid progress of nanomedicine.Drug delivery and translational research · 2020
    Article
  8. A few clarifications on MIRIBEL.Nature nanotechnology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Helena F FlorindoResearch Institute for Medicines, iMed.ULisboa, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal. hflorindo@ff.ulisboa.pt.
Asaf MadiDepartment of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. asafmadi@gmail.com.
Ronit Satchi-FainaroDepartment of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ronitsf@tauex.tau.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NanomedicineNanotechnologyEditorial PoliciesHumansPeriodicals as TopicReproducibility of ResultsResearch

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.